The Druley lab awarded RO1

The National Cancer Institute awarded the Druley Lab a 5-year RO1 award to apply Error-Corrected Sequencing (ECS) to study children with de novo¬†acute myeloid leukemia (AML). In collaboration with the Children’s Oncology Group, we will apply¬†ECS to characterize approximately 2,000 samples from children treated in the largest AML study ever […]